Navigation Links
Highly Regarded Medical Writer Joins Avant Healthcare Marketing Team
Date:5/24/2010

CARMEL, Ind., May 24 /PRNewswire/ -- Dynamic, thorough, and robustly qualified are a few of the many adjectives applied to our newest Scientific Content Consultant, Philippe Vitat, who brings with him expertise and an abundance of experience in the field. Mr. Vitat has worked as a certified medical writer and editor since 2001 and was named a "Leading Health Professional of the World" in medical education by the International Biographical Center in Cambridge, England. As a medical writer, he provided strategic consulting services in medical communications for major manufacturers, including Eli Lilly and Company, Ethicon, GlaxoSmithKline, AstraZeneca, Prometheus, Novartis, Eisai, and Sanofi-Aventis.

Mr. Vitat's therapeutic specialties include neuroscience, oncology, dermatology, gastroenterology, infectious diseases, and cardiovascular diseases, among others. He co-founded and served as medical editor of IMPACT, a Digestive Diseases Educational Center-produced regional CME symposium series, which continues to provide periodical clinical updates on digestive diseases, metabolic disorders, and infectious diseases throughout the United States.

Before working as a freelance medical writer, Mr. Vitat was Vice President and Group Account Supervisor at Grey Healthcare Group, a New York-based global healthcare communications company. While at Grey, he led numerous account teams that provided clients with project management support and elaborated a multi-faceted medical communications plan, which led, among other achievements, to the successful launch of Aciphex and Celexa. He also managed all operational aspects of the strategic partnership with Lilly leading to the global launch of the innovative biological agent Xigris.

Mr. Vitat received his baccalaureate in Economics at the College Sainte Marie in Antony, France, in 1987. He received his masters in Management with honors at the Ecole des Dirigeants et Createurs d'entreprise in Paris, France, in 1990 and his certificate in medical writing and editing at the University of Chicago Graham School of General Studies in 2008.

Avant Healthcare Marketing is recognized as a leader in peer-to-peer marketing for pharmaceutical and biotechnology companies who need comprehensive communication strategies and plans. Avant delivers superior medical and health education across multiple channels to healthcare professionals to improve patient outcomes.

www.AvantHCM.com

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Philippe Vitat

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=95318


'/>"/>
SOURCE Avant Healthcare Marketing
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vi typhoid vaccine proves highly effective in young children
2. Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM)
3. Thomson Reuters Examines Highly Cited Research in Bioterrorism
4. Scientists determine the structure of highly efficient light-harvesting molecules in green bacteria
5. NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains
6. HOGGAN Ergo Announces Highly Anticipated Enhancements to the ergoFET Handheld Digital Force Gauge, Greatly Impacting the Field of Ergonomic Research and Application
7. U.S. Risks Losing Highly Skilled Immigrants
8. NicOx Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen
9. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
10. Pharmatek Announces Official Opening of New Highly-Potent & Cytotoxic Development and Manufacturing Facility
11. Scientists demonstrate highly directional semiconductor lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... -- Four US Biotech equities have been ... are: Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), Arrowhead Pharmaceuticals Inc. ... and Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ). ... are growing more bullish on the sector as a ... cash held overseas for tax reason by large US ...
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... SAN FRANCISCO, CA (PRWEB) , ... February 24, 2017 , ... ... awarding of a $224K grant from the National Institute of Mental Health (NIMH) for ... is based on Delpor’s PROZOR technology and is expected to deliver therapeutic ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new ... Identity Strategy Partners, LLP (IdSP) . Designed to fill ... the complex identity market, founding partners Mark Crego ... 35 combined years just in identity expertise that span ... and non-profit leadership. The Crego-Kephart combined expertise has a ...
(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:2/1/2017)... 1, 2017 IDTechEx Research, a leading provider ... announces the availability of a new report, Sensors for Robotics: ... Continue Reading ... ... robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts ...
Breaking Biology News(10 mins):